Prediction of Therapeutic Targets for Pharmacological Intervention in Alcoholism through Signaling Pathway Enrichment Analysis of Prefrontal Cortex RNA-seq Data
Main Article Content
Abstract
The aim of this study was to predict targets for the pharmacological correction of alcoholism by enriching biological processes with transcriptional data from postmortem material of the human dorsolateral prefrontal cortex. RNA-seq data from 96 patients from the open GEO database was analyzed. Differential expression analysis was performed using the DESeq2 method. Enrichment of biological processes was performed using the GSEA method against the GO:BP database. Connectivity Map analysis was used to identify pharmacological agents. Sixty-one significantly differentially expressed genes were detected. Using GSEA, we identified the relationship between changes in gene expression and biological processes in the body. Connectivity Map analysis identified three pharmacological classes with a potential effect correcting the predicted changes: JAK kinase inhibitors, ATPase inhibitors, and chemokine receptor antagonists.
Article Details
References
- GBD 2021 Diseases and Injuries Collaborators. (2024). Global burden of disease. IHME.
- Shabanov, P. D., & Kalishevich, S. Y. (1998). Biologiya alkogolizma. Lan, St. Petersburg, 272 p.
- Shabanov, P. D. (2012). Narkologiya: rukovodstvo dlya vrachey GEOTARMedia, Moscow, 832 p.
- Nippert, K. E., Rowland, C. P., & Moorman, D. E. (2024). Alcohol, flexible behavior, and the prefrontal cortex. Neuropharmacology, 250, 109920. DOI
- Airapetov, M. I., Eresko, S. O., Lebedev, A. A., Bychkov, E. R., & Shabanov, P. D. (2020). Role of toll-like receptors in the neuroimmunology of alcoholism. Biomeditsinskaya Khimiya, 66(3), 208–215. DOI
- Crews, F. T., & Vetreno, R. P. (2016). Mechanisms of neuroimmune gene induction in alcoholism. Psychopharmacology, 233(9), 1543–1557. DOI
- Ye, J.-H., Zuo, W., Chaudhry, F., & Chinn, L. (2025). Neuroimmune mechanisms in alcohol use disorder: Microglial modulation and therapeutic horizons. Psychoactives, 4(3), Article 33. DOI
- Pascual, M., Montesinos, J., & Guerri, C. (2018). Neuroimmune signaling in alcohol use disorder. Pharmacology Biochemistry and Behavior, 177, 34–60. DOI
- Wu, C., Bendriem, R. M., Garamszegi, S. P., Shu, J., & Lee, C.-T. (2017). RNA sequencing in post-mortem human brains of neuropsychiatric disorders. Psychiatry and Clinical Neurosciences, 71(10), 663–672. DOI
- Willis, C., White, J. D., Minto, M. S., Quach, B. C., Han, S., Tao, R., Shin, J. H., Johnson, E. O., & Hancock, D. B. (2024). Gene expression differences associated with alcohol use disorder in human brain. Molecular Psychiatry. Advance online publication. DOI
- Love, M. I., Huber, W., & Anders S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15(12), 550. DOI
- Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai Z., Feng, T., Zhou, L., Tang, W., Zhan, L., Fu, X., Liu, S., Bo, X., & Yu, G. (2021). clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation, 2(2), 100141. DOI
- Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., Lahr, D. L., Hirschman, J. E., Liu, Z., Donahue, M., Julian, B., Khan, M., Wadden, D., Smith, I. C., Lam, D., . . . DeLuca, M. (2017). A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell, 171(6), 1437–1452. DOI
- Abernathy, K., Harris, R. A., & Mayfield, R. D. (2022). Alcohol use disorder: Neurobiology and therapeutics. Biomedicines, 10(5), 1192. DOI
- Ketlinsky, S. A., & Simbirtsev, A. S. (2008). Cytokines. Foliant, St. Petersburg, 552 p.
